Gastrodia elata polysaccharide alleviates Parkinson's disease via inhibiting apoptotic and inflammatory signaling pathways and modulating the gut microbiota

Qing-xia Gan, Mao-yao Peng, Hao-bo Wei, Lin-lin Chen, Xiao-yan Chen, Zi-han Li, Guang-qin An and Yun-tong Ma

Food Funct., 2024, 15, 2920
DOI: 10.1039/D3FO05169B

Integrated multi-omics profiling highlights the benefits of resveratrol hydroxypropyl-β-cyclodextrin inclusion complex for A53T transgenic mice through the microbiota–gut–brain axis

Xiaodong Sun, Shenglan Feng, Bingqing Qin, Junjie Ye, Lixia Xie, Jianjun Gui and Ming Sang

Food Funct., 2024, 15, 1489
DOI: 10.1039/D3FO03667G

Therapeutic Effect of Resveratrol and its Novel Formulations on Lung Cancer: Focus on Biological Aspects and Underlying Pathways

Hamidreza Poortalebi, Mahta ZareDini, Sima Foroughi-Nematollahi, Tahereh Farkhondeh, Saeed Samarghandian and Mohammad Hossein Pourhanifeh

CMC, 2024, 31, 4340
DOI: 10.2174/0109298673266259231229050937

T-2 toxin-induced spatial learning and memory impairment in mice via the gut-brain axis and the intervening effects of resveratrol

Sheng-Quan Su, Gui-Yuan Xiong, Chun-Yan Yao, Xiao-Ling Liu, Yin-Yin Xia, Jin-Yun Long, Xiu-Kuan Li, Liang-Mei Wang, Long Yi, Wu-Wei Xu, Wu-Qiang Lu, Qian-Qian Li, Ting Hu, Hao Liu, Ke-Xue Wang, Peng Luo and Tong-Jian Cai

Ecotoxicology and Environmental Safety, 2025, 302, 118623
DOI: 10.1016/j.ecoenv.2025.118623

The Interaction Between Nutraceuticals and Gut Microbiota: a Novel Therapeutic Approach to Prevent and Treatment Parkinson’s Disease

Liyan Yao, Yong Yang, Xiaowei Yang and Mohammad J. Rezaei

Mol Neurobiol, 2024, 61, 9078
DOI: 10.1007/s12035-024-04151-2

17β-Trenbolone Exposure Enhances Muscle Activity and Exacerbates Parkinson’s Disease Progression in Male Mice

Xiang Zuo, Hui-Juan Bai, Qi-Li Zhao, Shu-Hui Zhang, Xin Zhao and Xi-Zeng Feng

Mol Neurobiol, 2025, 62, 3053
DOI: 10.1007/s12035-024-04455-3

The role of the gut microbiota in neuropsychiatric disorders and therapy

Fan Zhang, Kang Ding, Lin-Mei Zhang, Dong-Yao Liu, Xin Dong, Man-Ni Wang, Fu-Lin Zhou, Yi-Wei Sun, Wei-Ku Zhang, Yu Yan, Jun He and Jie-Kun Xu

Ageing Research Reviews, 2025, 102894
DOI: 10.1016/j.arr.2025.102894

Pharmacodynamical research of extracts and compounds in traditional Chinese medicines for Parkinson's disease

Mengmeng Li, Hanze Wang, Yuxin Bai, Fuyu Xiong, Shifei Wu, Qirui Bi, Yajun Qiao, Yan Zhang, Xiaolan Li, Lin Feng and De-an Guo

Fitoterapia, 2024, 177, 106086
DOI: 10.1016/j.fitote.2024.106086

The Potential of Edible and Medicinal Resource Polysaccharides for Prevention and Treatment of Neurodegenerative Diseases

Qingxia Gan, Yugang Ding, Maoyao Peng, Linlin Chen, Jijing Dong, Jiaxi Hu and Yuntong Ma

Biomolecules, 2023, 13, 873
DOI: 10.3390/biom13050873

Herbal Interventions in Parkinson’s Disease: A Systematic Review of Preclinical Studies

Wanlin Zhao, Hailiang Cui, Jihong Liu, Hongyu Sun, Zijuan Zhang, Zhenqiang Zhang and Dongrui Ma

Cell Mol Neurobiol, 2025, 45
DOI: 10.1007/s10571-025-01556-y

Withaferin A maintained microbiome and metabolome features in A53T transgenic mice via multi-omics integrated analysis

Xiaodong Sun, Bingqing Qin, Ai Guo, Jianjun Gui, Jingjing Weng, Junjie Ye, Shenglan Feng and Ming Sang

Phytomedicine, 2025, 141, 156725
DOI: 10.1016/j.phymed.2025.156725

Gut Microbiota-Based Interventions for Parkinson’s Disease: Neuroprotective Mechanisms and Current Perspective

Deepak Kumar, Mahendra Bishnoi, Kanthi Kiran Kondepudi and Shyam Sunder Sharma

Probiotics & Antimicro. Prot., 2025, 17, 2438
DOI: 10.1007/s12602-024-10433-x

Time association study on a sub-acute mouse model of Parkinson’s disease

Jinfeng Ren, Tongzheng Liu, Luyan You, Minghui Hu, Jianping Zhu, Xinyu Wang, Hao Zhang, Jiayu Zhang, Zifa Li, Sheng Wei and Xiwen Geng

Heliyon, 2024, 10, e34082
DOI: 10.1016/j.heliyon.2024.e34082

Research progress on natural products in regulating the gut microbiota in Parkinson’s disease

Ying Jia, Yuanyuan Zhang, Xin Tai, Tengyu Zhao, Hanwen Zhang and Haichun Zhou

Front. Pharmacol., 2025, 16
DOI: 10.3389/fphar.2025.1667694

Gut Microbiota Defined Epigenomes of Alzheimer’s and Parkinson’s Diseases Reveal Novel Targets for Therapy

Shabnam Nohesara, Hamid Mostafavi Abdolmaleky, Sam Thiagalingam and Jin-Rong Zhou

Epigenomics, 2024, 16, 57
DOI: 10.2217/epi-2023-0342

Gut microbial dysbiosis aggravated Parkinson-like pathology induced by MPTP/probenecid

Qiu-Zhu Chen, Jun-Mei Shang, Yue-Qi Jiang, Yang Yang, Cai-Xia Zang, Jing-Wei Ma, Yi-Rong Dong, Jin-Rong Wang, Ning Zhou, Xing Yang, Fang-Fang Li, Xiu-Qi Bao and Dan Zhang

Physiology & Behavior, 2025, 299, 115008
DOI: 10.1016/j.physbeh.2025.115008

The microbiota-gut-brain axis: a potential target in the small-molecule compounds and gene therapeutic strategies for Parkinson’s disease

Fengjuan Jiao, Lincong Zhou and Zaixin Wu

Neurol Sci, 2025, 46, 561
DOI: 10.1007/s10072-024-07878-x

Exploring the causal relationship between periodontitis and gut microbiome: Unveiling the oral–gut and gut–oral axes through bidirectional Mendelian randomization

Hang Chen, Limin Peng, Zhenxiang Wang, Yujuan He and Xiaonan Zhang

J Clinic Periodontology, 2024, 51, 417
DOI: 10.1111/jcpe.13906

Gut Microbial Metabolome and Dysbiosis in Neurodegenerative Diseases: Psychobiotics and Fecal Microbiota Transplantation as a Therapeutic Approach—A Comprehensive Narrative Review

Sara Uceda, Víctor Echeverry-Alzate, Manuel Reiriz-Rojas, Esther Martínez-Miguel, Ana Pérez-Curiel, Silvia Gómez-Senent and Ana Isabel Beltrán-Velasco

IJMS, 2023, 24, 13294
DOI: 10.3390/ijms241713294

Dietary (Poly)phenols and the Gut–Brain Axis in Ageing

Léonie Láng, Simon McArthur, Alpar S. Lazar, Line Pourtau, David Gaudout, Matthew G. Pontifex, Michael Müller and David Vauzour

Nutrients, 2024, 16, 1500
DOI: 10.3390/nu16101500